SINOCOM PHARMACEUTICAL, INC. (CIK: 0001434017) EDGAR, Information, Filings... CompaniesBIO.Com

SINOCOM PHARMACEUTICAL, INC.

Mailing address
ROOM 3, 21/F, FAR EAST CONSORTIUM BLDG, 121 DES VOEUX ROAD, CENTRAL, Nevada, 99999
Phone
852- 2159-7863
State location
Hong Kong
State of incorporation
Nevada
Fiscal year end
December 31
SIC
5122 - (CF Office: Office of Trade & Services) WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Filings
N/A

SINOCOM PHARMACEUTICAL, INC. (CIK: 0001434017) is an American company incorporated in the state of Hong Kong. Head office is located at ROOM 3, 21/F, FAR EAST CONSORTIUM BLDG, 121 DES VOEUX ROAD, CENTRAL, Hong Kong, 99999. Work in the industry 5122 - (CF Office: Office of Trade & Services) WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES. SINOCOM PHARMACEUTICAL, INC. is a public company and trade via Over-The-Counter (OTC).

Old names:

Tiger Acquisitions, Inc. from 2008-01-May to 2009-27-Feb

Owner	Filings	Transaction Date	Type of Owner
Leung Stanley	0001478509	Dec-03-2009	director
Ai Xue Xaing	0001457462	Feb-20-2009	10 percent owner, officer: Chief Executive Officer
Wan Chi Kwong	0001457463	Feb-20-2009	director, 10 percent owner
Pang Tuck Wing	0001457464	Feb-20-2009	officer: Chief Financial Officer
Eastern Wealthy International Invest Ltd	0001457789	Feb-20-2009	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SINOCOM PHARMACEUTICAL, INC.

Filings	Format	Description	Filed/Effective	File/Film Number
RW	Document	Registration Withdrawal Request Acc-no: 0001137050-11-000327 (NE Act) Size: KB	Oct-18-2011	333-173958 111147224
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001137050-11-000320 (34 Act) Size: KB	Oct-14-2011	000-53213 111142536
RW	Document	Registration Withdrawal Request Acc-no: 0001137050-11-000315 (NE Act) Size: KB	Oct-13-2011	333-173941 111138945
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001137050-11-000301 (34 Act) Size: KB	Sep-15-2011	000-53213 111092229
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001137050-11-000214 (34 Act) Size: KB	Aug-15-2011	000-53213 111036674
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001137050-11-000116 (34 Act) Size: KB	May-20-2011	000-53213 11861024
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001137050-11-000108 (34 Act) Size: KB	May-16-2011	000-53213 11845253
S-1	Document	General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001193125-11-128619 (33 Act) Size: KB	May-05-2011	333-173958 11815288
S-1	Document	General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001193125-11-127736 (33 Act) Size: KB	May-05-2011	333-173941 11813150
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001137050-11-000083 (34 Act) Size: KB	Apr-15-2011	000-53213 11763816
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001137050-11-000066 (34 Act) Size: KB	Mar-30-2011	000-53213 11720735
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001137050-10-000268 (34 Act) Size: KB	Dec-29-2010	005-84768 101279015
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001137050-10-000267 ( Act) Size: 0 KB	Dec-29-2010
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001137050-10-000241 (34 Act) Size: KB	Nov-15-2010	000-53213 101192558
UPLOAD	Document	Acc-no: 0000000000-10-059315 ( Act) Size: KB	Oct-07-2010
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001137050-10-000203 (34 Act) Size: KB	Oct-07-2010	000-53213 101113465
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001137050-10-000202 (34 Act) Size: KB	Oct-06-2010	000-53213 101111726
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001137050-10-000197 ( Act) Size: KB	Oct-04-2010
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001137050-10-000194 (34 Act) Size: KB	Sep-29-2010	000-53213 101096088
UPLOAD	Document	Acc-no: 0000000000-10-056371 ( Act) Size: KB	Sep-24-2010

Recent 20 filings. View all SINOCOM PHARMACEUTICAL, INC. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

SINOCOM PHARMACEUTICAL, INC. overview
SINOCOM PHARMACEUTICAL, INC. job
SINOCOM PHARMACEUTICAL, INC. stock
SINOCOM PHARMACEUTICAL, INC. ownership
SINOCOM PHARMACEUTICAL, INC. CEO
SINOCOM PHARMACEUTICAL, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.